NASDAQ:MAMO Stock Quote
Massimo Group is a healthcare technology company that specializes in non-invasive monitoring solutions for patient care
The company focuses on developing advanced medical devices that provide real-time insight into a patient's physiological status, enhancing clinicians' ability to deliver timely and effective healthcare. Its innovative products are designed to improve patient outcomes in various clinical settings, ranging from hospitals to outpatient care. Massimo Group is dedicated to advancing medical technology to facilitate better decision-making and ultimately enhance the quality of care delivered to patients.
Frequently Asked Questions
Does Massimo Group have any partnerships?
Yes, Massimo Group has established various partnerships with healthcare providers, academic institutions, and technology companies to enhance its product development and distribution capabilities. These collaborations play a critical role in expanding its innovation framework and improving patient care.
Has Massimo Group received any awards?
Massimo Group has received numerous accolades for its commitment to innovation and excellence in healthcare technology. They have been recognized for their contributions to non-invasive monitoring and for their role in enhancing patient safety and comfort in medical settings.
How does Massimo Group ensure product quality?
Massimo Group adheres to rigorous quality control measures and operates under established quality management systems compliant with international standards, such as ISO 13485. They maintain strict testing protocols and continuously monitor product performance to ensure their devices meet the highest standards of safety and effectiveness.
How does Massimo Group handle customer support?
Massimo Group places a high priority on customer support, providing comprehensive training, technical assistance, and product service to its clients. Their dedicated customer support team ensures that healthcare providers can effectively utilize their technologies to improve patient care.
How does Massimo Group promote innovation?
Massimo Group invests significantly in research and development to foster innovation within its product line. The company collaborates with healthcare professionals and academic institutions to identify unmet clinical needs and develop cutting-edge technologies that advance patient monitoring.
Is Massimo Group publicly traded?
Yes, Massimo Group is publicly traded on the Nasdaq stock exchange under the ticker symbol MAMO. The company began trading publicly in 2020, marking a significant milestone in its growth strategy and enabling it to raise capital for continued innovation.
What are the future plans for Massimo Group?
Massimo Group plans to expand its product portfolio, invest in new technologies, and enhance its presence in international markets. The company aims to continue its mission of improving patient monitoring and care while exploring opportunities for strategic partnerships and acquisitions in the healthcare sector.
What clinical applications does Massimo's technology support?
Massimo's technology supports a wide range of clinical applications, including perioperative monitoring, critical care scenarios, and chronic disease management. Their devices facilitate real-time monitoring of vital signs during surgery, emergencies, and in routine outpatient care.
What does Massimo Group do?
Massimo Group is a leading company specializing in the development and commercialization of innovative medical technologies focused on the non-invasive monitoring of patients. The company is dedicated to improving patient outcomes by providing advanced solutions that enhance clinical capabilities in various healthcare settings.
What financial growth has Massimo Group experienced?
Since its initial public offering, Massimo Group has reported consistent revenue growth driven by increased demand for its monitoring technologies. The company has strategically expanded its product offerings and market reach, enhancing its financial performance even amidst the competitive landscape.
What industries does Massimo Group serve?
Massimo Group primarily serves the healthcare industry, including hospitals, clinics, and home care settings. Their products cater to various departments such as critical care, anesthesia, emergency medicine, and outpatient settings where continuous patient monitoring is essential.
What is the focus of Massimo Group's research and development?
The focus of Massimo Group's research and development efforts is to create non-invasive monitoring solutions that enhance clinical decision-making and improve patient outcomes. Their R&D activities aim to address the evolving needs of healthcare providers through innovative technologies.
What makes Massimo's technology unique?
Massimo's technology is distinguished by its proprietary SET® pulse oximetry, which provides highly accurate and reliable measurements even in challenging clinical conditions. This innovation allows for non-invasive monitoring, reducing the need for more invasive procedures and improving patient comfort and safety.
What products does Massimo Group offer?
Massimo Group offers a range of advanced medical devices and technologies, including vital signs monitors, non-invasive blood glucose tracking devices, and assorted monitoring software. Their flagship product, the SET® pulse oximetry technology, is widely recognized for its accuracy and reliability in measuring oxygen saturation and pulse rate.
What regulatory standards does Massimo Group comply with?
Massimo Group complies with strict regulatory standards set by agencies such as the FDA in the United States and the European Medicines Agency in Europe. This ensures that their devices are safe, effective, and suitable for clinical use across different healthcare systems.
When was Massimo Group founded?
Massimo Group was founded in 1989 by Dr. Jan B. J. De Vries and a group of dedicated engineers and medical professionals who aimed to revolutionize patient monitoring. The company has since grown significantly and has established itself as a leader in the healthcare technology space.
Where is Massimo Group headquartered?
Massimo Group is headquartered in Irvine, California. This location serves as the hub for its research and development efforts, as well as its corporate operations and strategic initiatives aimed at expanding its market presence.
Who are Massimo Group's competitors?
Massimo Group faces competition from various companies in the medical technology sector, including big players such as Philips Healthcare, Medtronic, GE Healthcare, and Siemens Healthineers. However, Massimo differentiates itself through its innovative, non-invasive monitoring solutions.
What is the current price of Massimo Group - Common Stock?
The current price of Massimo Group - Common Stock is 2.720
When was Massimo Group - Common Stock last traded?
The last trade of Massimo Group - Common Stock was at 4:00 pm EDT on April 2nd, 2025